Details of Host Protein
Host Protein General Information (ID: PT1210) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
U8 snoRNA-decapping enzyme (NUDT16)
|
Gene Name |
NUDT16
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
NUD16_HUMAN
|
||||||
Protein Families |
Nudix hydrolase family
|
||||||||
EC Number |
3.6.1.62; 3.6.1.64
|
||||||||
Subcellular Location |
Nucleus; nucleoplasm Nucleus; nucleolus Cytoplasm
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
RNA-binding and decapping enzyme that catalyzes the cleavageof the cap structure of snoRNAs and mRNAs in a metal-dependent manner. Part of the U8 snoRNP complex that is required for the accumulation ofmature 5. 8S and 28S rRNA. Has diphosphatase activity and removes m7Gand/or m227G caps from U8 snoRNA and leaves a 5'monophosphate on theRNA. Catalyzes also the cleavage of the cap structure on mRNAs. Doesnot hydrolyze cap analog structures like 7-methylguanosine nucleosidetriphosphate (m7GpppG). Also hydrolysis m7G- and m227G U3-capped RNAsbut with less efficiencies. Has broad substrate specificity withmanganese or cobalt as cofactor and can act on various RNA species. Binds to the U8 snoRNA; metal is not required for RNA-binding. May playa role in the regulation of snoRNAs and mRNAs degradation. Acts also asa phosphatase; hydrolyzes the non-canonical purine nucleotides inosinediphosphate (IDP) and deoxyinosine diphosphate (dITP) as well asguanosine diphosphate (GDP), deoxyguanosine diphosphate (dGDP), xanthine diphosphate (XDP), inosine triphosphate (ITP) and deoxyinosinetriphosphate (ITP) to their respective monophosphate derivatives anddoes not distinguish between the deoxy- and ribose forms. The order of activity withdifferent substrates is IDP > dIDP >> GDP = dGDP > XDP = ITP = dITP. Binds strongly to GTP, ITP and XTP. Participates inthe hydrolysis of dIDP/IDP and probably excludes non-canonical purinesfrom RNA and DNA precursor pools, thus preventing their incorporationinto RNA and DNA and avoiding chromosomal lesions. Exhibits decapping activity towards NAD-capped RNAs and FAD-capped RNAs. Exhibits decapping activity towards dpCoA-cappedRNAs in vitro.
[1-3]
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
RNA degradation | hsa03018 |
Pathway Map ![]() |
|||||||
Metabolic pathways | hsa01100 |
Pathway Map ![]() |
|||||||
Nucleotide metabolism | hsa01232 |
Pathway Map ![]() |
|||||||
Purine metabolism | hsa00230 |
Pathway Map ![]() |
|||||||
RNA degradation | hsa03018 |
Pathway Map ![]() |
|||||||
Metabolic pathways | hsa01100 |
Pathway Map ![]() |
|||||||
Nucleotide metabolism | hsa01232 |
Pathway Map ![]() |
|||||||
Purine metabolism | hsa00230 |
Pathway Map ![]() |
|||||||
3D Structure |
|
Function of This Protein During Virus Infection | |||||||||
---|---|---|---|---|---|---|---|---|---|
Virus Name | SARS-COV-2 | Protein Function | Pro-viral | [4] | |||||
Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
Method Description | To detect the role of host protein NUDT16 in viral infection, NUDT16 protein knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
Results | It is reported that knockout of NUDT16 leads to the decreased SARS-CoV-2 RNA levels compared with control group. |
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: ORF10 (hCoV-19/Not Specified Virus Strain ) | |||||||||
RNA Region Details |
RNA Info
![]() |
[5] | |||||||
Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
RNA Binding Region |
ORF10
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Huh7 cells (human liver cell line) (CVCL_0336 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Interaction Score | P-value < 0.05 | ||||||||
Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) |